OCTOBER 9, 2019

Publications Recent high-impact publications from Rogel Cancer Center members.

BASIC SCIENCES

Publications from members of the Cancer Biology, Cancer Genetics, Cancer Hematopoiesis and Developmental Therapeutics programs

Lee, Y.; Sugihara, K.; Gillilland, M. G. 3rd; Jon, S.; Kamada, N.; Moon, J. J. Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis. Nat Mater (2019) In process. PMID: 31427744.

CANCER CONTROL AND POPULATION SCIENCES

Publications from members of the Cancer Epidemiology and Prevention & Health Behavior and Outcomes programs

Wallner, L. P.; Reyes-Gastelum, D.; Hamilton, A. S.; Ward, K. C.; Hawley, S. T.; Haymart, M. R. Patient-Perceived Lack of Choice in Receipt of Radioactive Iodine for Treatment of Differentiated Thyroid Cancer. J Clin Oncol (2019) 37:2152-2161. PMID: 31283406. PMCID: PMC6698919. Stoffel, E. M.; Murphy, C. C. Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults. Gastroenterology (2019) In process. PMID: 31394082. Sheetz, K. H.; Chhabra, K. R.; Smith, M. E.; Dimick, J. B.; Nathan, H. Association of Discretionary Hospital Volume Standards for High-risk Cancer Surgery With Patient Outcomes and Access, 2005-2016. JAMA Surg (2019) In process. PMID: 31411663. PMCID: PMC6694402. Platt, K. D.; Kurlander, J. E.; Zikmund-Fisher, B. J.; Lipson, R.; Knaus, M.; Waljee, A. K.; Saini, S. D. Rethinking the Re-Prep: Attitudes Toward Noninvasive Colorectal Cancer Screening Tests After Inadequate Bowel Preparation. Am J Gastroenterol (2019) In process. PMID: 31464741.

COLLABORATIVE PUBLICATIONS

Interdisciplinary collaborations between Basic Sciences, Cancer Control and Population Sciences, & Translational and Clinical Research members

Cuneo, K. C.; Morgan, M. A.; Sahai, V.; Schipper, M. J.; Parsels, L. A.; Parsels, J. D.; Devasia, T.; Al-Hawaray, M.; Cho, C. S.; Nathan, H.; Maybaum, J.; Zalupski, M. M.; Lawrence, T. S. Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer. J Clin Oncol (2019). PMID: 31398082.

We want to hear your feedback! Please submit your thoughts about our new internal emails here.

Please forward this message to your colleagues. They can subscribe to these messages here.

‌ ‌ ‌

M-LINE 800-962-3555 | BLOG michiganhealthlab.org INTRANET  med.umich.edu/i/cancer/index.html